Clinical trial
Lipoic Acid for Neuroprotection in Secondary Progressive MS
NCT01188811 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Lipoic Acid for Neuroprotection in Secondary Progressive MS
- Lead sponsor
- VA Office of Research and Development
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- October 31, 2010
- Completion date
- August 31, 2015
- Enrollment
- 54 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.